NDC product
PUBLIX SUPER MARKETS INC
NDC 56062-305 · PUBLIX SUPER MARKETS INC
Key facts
| Product NDC | 56062-305 |
|---|---|
| Proprietary name | PUBLIX SUPER MARKETS INC |
| Nonproprietary name | ACETAMINOPHEN, ASPIRIN and CAFFEINE |
| Substances | ACETAMINOPHEN, ASPIRIN, CAFFEINE |
| Dosage form | TABLET |
| Route | ORAL |
| Labeler | PUBLIX SUPER MARKETS INC |
| Product type | HUMAN OTC DRUG |
| Marketing category | ANDA |
| Application number | ANDA214039 |
| Pharmacologic classes | Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE] and 5 more |
| Marketing start | Feb 23, 2024 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: